申请人:PARATEK PHARMACEUTICALS, INC.
公开号:US20160046561A1
公开(公告)日:2016-02-18
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
本发明至少部分涉及新型取代
四环素化合物。这些
四环素化合物可用于治疗许多对
四环素化合物敏感的疾病状态,如细菌感染和肿瘤。